Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wasan

Showing results (471-480 of 1,139) with videos related to

Pageof 114
Sort By:
Pharmaceutical Research|August 18, 1999
Cyclosporine transfer from low- and high-density lipoproteins is partially influenced by lipid transfer protein I triglyceride transfer activityK M Wasan, R Subramanian, J W Chou, et al.
The New Zealand Medical Journal|January 29, 2003
Adverse events in New Zealand public hospitals I: occurrence and impactPeter Davis, Roy Lay-Yee, Robin Briant, et al.
AAPS Pharmsci|April 26, 2003
Effects of disodium ascorbyl phytostanol phosphates (FM-VP4) on cholesterol accumulation within rat intestinal cellsKishor M Wasan, Edwin Yau, Kathy D Boulanger, et al.
Kidney International Reports|September 22, 2025
Monitoring Sodium Intake With a Salt Meter in Hemodialysis PatientsWilaiporn Akkabut, Wasan Trakulsuntornchai, Sutasiny Junhoaton, et al.
Metabolism: Clinical and Experimental|April 18, 2003
Disodium ascorbyl phytostanyl phosphate reduces plasma cholesterol concentrations and atherosclerotic lesion formation in apolipoprotein E-deficient miceTatjana Lukic, Kishor M Wasan, Daniela Zamfir, et al.
The New Zealand Medical Journal|October 29, 2003
Adverse events in New Zealand public hospitals II: preventability and clinical contextPeter Davis, Roy Lay-Yee, Robin Briant, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|December 12, 2001
Assessing the plasma pharmacokinetics, tissue distribution, excretion and effects on cholesterol pharmacokinetics of a novel hydrophilic compound, FM-VP4, following administration to ratsK M Wasan, K D Peteherych, S Najafi, et al.
Cureus|April 5, 2024
Challenges in Diagnosis and Management of Infantile Deep Neck Abscess: A Case Report and Literature ReviewHeba K Alkoheji, Wasan M Alharbi, Fatima N Abulfateh, et al.
Journal of Nanoscience and Nanotechnology|February 17, 2018
Thermally Deposited Palladium-Tungsten Carbide and Platinum-Tungsten Carbide Counter Electrodes for a High Performance Dye-Sensitized Solar Cell Based on Organic T<sup>-</sup>/T₂ ElectrolyteMadsakorn Towannang, Anongnad Thiangkaew, Wasan Maiaugree, et al.
Pharmaceutical Research|May 23, 2006
The in vitro plasma distribution of a novel cholesteryl ester transfer protein inhibitor, torcetrapib, is influenced by differences in plasma lipid concentrationsS D Lee, K M Wasan, A Calcagni, et al.
Pageof 114

Showing results (471-480 of 1,139) with videos related to

Sort By:
Pageof 114
Pharmaceutical Research|August 18, 1999
Cyclosporine transfer from low- and high-density lipoproteins is partially influenced by lipid transfer protein I triglyceride transfer activityK M Wasan, R Subramanian, J W Chou, et al.
The New Zealand Medical Journal|January 29, 2003
Adverse events in New Zealand public hospitals I: occurrence and impactPeter Davis, Roy Lay-Yee, Robin Briant, et al.
AAPS Pharmsci|April 26, 2003
Effects of disodium ascorbyl phytostanol phosphates (FM-VP4) on cholesterol accumulation within rat intestinal cellsKishor M Wasan, Edwin Yau, Kathy D Boulanger, et al.
Kidney International Reports|September 22, 2025
Monitoring Sodium Intake With a Salt Meter in Hemodialysis PatientsWilaiporn Akkabut, Wasan Trakulsuntornchai, Sutasiny Junhoaton, et al.
Metabolism: Clinical and Experimental|April 18, 2003
Disodium ascorbyl phytostanyl phosphate reduces plasma cholesterol concentrations and atherosclerotic lesion formation in apolipoprotein E-deficient miceTatjana Lukic, Kishor M Wasan, Daniela Zamfir, et al.
The New Zealand Medical Journal|October 29, 2003
Adverse events in New Zealand public hospitals II: preventability and clinical contextPeter Davis, Roy Lay-Yee, Robin Briant, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|December 12, 2001
Assessing the plasma pharmacokinetics, tissue distribution, excretion and effects on cholesterol pharmacokinetics of a novel hydrophilic compound, FM-VP4, following administration to ratsK M Wasan, K D Peteherych, S Najafi, et al.
Cureus|April 5, 2024
Challenges in Diagnosis and Management of Infantile Deep Neck Abscess: A Case Report and Literature ReviewHeba K Alkoheji, Wasan M Alharbi, Fatima N Abulfateh, et al.
Journal of Nanoscience and Nanotechnology|February 17, 2018
Thermally Deposited Palladium-Tungsten Carbide and Platinum-Tungsten Carbide Counter Electrodes for a High Performance Dye-Sensitized Solar Cell Based on Organic T<sup>-</sup>/T₂ ElectrolyteMadsakorn Towannang, Anongnad Thiangkaew, Wasan Maiaugree, et al.
Pharmaceutical Research|May 23, 2006
The in vitro plasma distribution of a novel cholesteryl ester transfer protein inhibitor, torcetrapib, is influenced by differences in plasma lipid concentrationsS D Lee, K M Wasan, A Calcagni, et al.
Pageof 114